About
Dr. Thomas Ramdahl is a pharmaceutical executive with over 25 years of clinical and development experience. In 2001, he became President and the first CEO of Algeta. He served in several senior positions within the company through to and post the acquisition of Algeta by Bayer in 2014, following the acquisition Thomas served as CEO of Bayer AS. Thomas currently serves on the boards of Precirix, Clarity Pharmaceuticals and Agiana Pharmaceuticals. Thomas has authored more than 40 publications and is a co-inventor of several patents. Thomas gained his PhD in environmental chemistry from the University of Oslo and holds a Master of Science in organic chemistry from the Norwegian Institute of Technology.
Sign up to see Thomas Ramdahl's full profile
Access investment thesis, focus areas, bio, and contact details for Thomas Ramdahl and 22,000+ other VC professionals.
HealthCap
Stockholm, SE